This 2020 retrospective study evaluated 875 patients post-radical prostatectomy, analyzing the effect of statin use on biochemical recurrence (BCR). Statin use at the time of surgery was reported in 45.7% of patients. Over a median follow-up of 51.2 months, statin users had a significantly reduced risk of BCR (HR 0.599,